The timing was deliberate. When Luminai announced a $38 million Series B round in April, the San Francisco startup paired the funding news with something far more valuable in the world of enterprise software: a live customer willing to talk about it.
That customer is Cleveland Clinic, which has started deploying Luminai's AI automation platform across its referral management operations—a notoriously tangled workflow that involves parsing faxes and emails, extracting patient details, matching records across systems, and routing requests to the right department. For a health system that operates 23 hospitals and logged north of 15 million patient encounters last year, the administrative drag is substantial. Cleveland Clinic is betting Luminai's AI agents can take some of that weight.
Peak XV Partners, the venture firm formerly known as Sequoia India & SEA, led the round. Define Ventures joined as a new investor, alongside returning backers General Catalyst and Y Combinator. The raise brings Luminai's total funding to $60 million—a figure that includes a $3.4 million seed in late 2020 and a $16 million Series A in June 2022.
An Advisor Network With Familiar Names
Luminai's advisor roster reads like a who's-who of healthcare's C-suite, past tense. Cleveland Clinic's former CEO Toby Cosgrove is listed, along with Bruce Broussard, who ran Humana until recently, and Frank Williams of Evolent Health. Define Ventures appears to have been the connective tissue there.
The investor syndicate is broader: Moxxie Ventures, Craft Ventures, Underscore VC, Unshackled Ventures, and Scribble Ventures all participated. So did a pair of notable angels—Bob McGrew and Kevin Weil, both formerly of OpenAI, where McGrew served as Chief Research Officer and Weil as Chief Product Officer. Their involvement suggests the company is drawing interest from those who've watched frontier AI models up close.
What Cleveland Clinic Is Actually Doing
The initial deployment focuses on referral intake, a process that remains stubbornly analog at many institutions. Luminai's software ingests the unstructured inputs—scanned documents, free-text messages—and applies Cleveland Clinic's own institutional rulebook to classify and route them. When the AI encounters something ambiguous, it kicks the case to a human.
That escalation mechanism matters. Healthcare operations teams have been burned before by automation that claims to solve everything and ends up creating new bottlenecks. Luminai's pitch, at least in its marketing materials, emphasizes preserving institutional knowledge rather than bulldozing it. Whether that plays out at Cleveland Clinic's scale remains to be seen, though the health system has signaled plans to expand the platform into other high-volume administrative areas.
The Broader Automation Thesis
Luminai's homepage claims the platform has executed more than 12 million automations to date. Customers reportedly deploy an average of seven use cases each, with the company citing a 48-day time-to-value window and 5.3x ROI on average. (Standard caveats apply: these are vendor-reported figures, not third-party audits.)
Use cases stretch across the administrative sprawl of healthcare: provider inbox management, patient registration, pharmacy renewals, payer contract wrangling, denials workflows. The company offers deployment flexibility—on-premises, customer-managed cloud, or Luminai's own infrastructure—and touts compliance with HIPAA, SOC 2, and GDPR.
The underlying bet is straightforward, if ambitious. Administrative costs consume somewhere between 15 and 25 percent of total healthcare spending in the United States, depending on whose estimate you trust. Luminai is arguing that AI agents, not just robotic process automation or rules-based systems, can chip away at that figure in a way that scales across fragmented hospital IT environments.
What Comes Next
Luminai plans to use the new capital to expand engineering and deployment teams, refine the product, and sign more enterprise customers. The company has grown to a headcount in the range of 30 to nearly 50 employees, with roles scattered across the Bay Area and New York.
CEO Kesava Kirupa Dinakaran appeared on a panel at the ViVE healthcare conference in recent months, part of a session billed as "The New Guard of Digital Health." That framing—new guard—might be aspirational. Healthcare moves slowly, especially when it comes to reworking core operational workflows.
But the Cleveland Clinic partnership offers something rare in the AI automation space: a public, production-scale test case. Not a pilot with a single department. Not a proof-of-concept limited to a few hundred transactions. A deployment meant to handle the operational complexity of a sprawling health system processing millions of patient encounters annually.
Whether that ambition translates into a repeatable playbook for other hospital networks—or becomes a cautionary tale about overpromising in a risk-averse industry—will likely determine how the next chapter of Luminai's story unfolds.
---
Founded in 2019 as DigitalBrain, Luminai went through Y Combinator's Summer 2020 batch and rebranded ahead of its Series A. Peak XV's involvement may extend further back; the firm's portfolio page indicates a partnership dating to the prior year, though details on earlier rounds weren't disclosed in this announcement.
